Gsa Capital Partners LLP Aurinia Pharmaceuticals Inc. Transaction History
Gsa Capital Partners LLP
- $1.35 Billion
- Q4 2024
A detailed history of Gsa Capital Partners LLP transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 11,758 shares of AUPH stock, worth $95,827. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,758
Previous 125,645
90.64%
Holding current value
$95,827
Previous $921,000
88.49%
% of portfolio
0.01%
Previous 0.07%
Shares
8 transactions
Others Institutions Holding AUPH
# of Institutions
227Shares Held
58.9MCall Options Held
949KPut Options Held
1.51M-
Black Rock Inc. New York, NY9.27MShares$75.6 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA8.43MShares$68.7 Million5.69% of portfolio
-
Armistice Capital, LLC New York, NY6.4MShares$52.2 Million0.81% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$32.4 Million2.55% of portfolio
-
State Street Corp Boston, MA2.92MShares$23.8 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.16B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...